1. Home
  2. SLDB vs NOTV Comparison

SLDB vs NOTV Comparison

Compare SLDB & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • NOTV
  • Stock Information
  • Founded
  • SLDB 2013
  • NOTV 1974
  • Country
  • SLDB United States
  • NOTV United States
  • Employees
  • SLDB N/A
  • NOTV N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • NOTV Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLDB Health Care
  • NOTV Health Care
  • Exchange
  • SLDB Nasdaq
  • NOTV Nasdaq
  • Market Cap
  • SLDB 124.7M
  • NOTV 128.0M
  • IPO Year
  • SLDB 2018
  • NOTV 1997
  • Fundamental
  • Price
  • SLDB $5.78
  • NOTV $4.06
  • Analyst Decision
  • SLDB Strong Buy
  • NOTV Strong Buy
  • Analyst Count
  • SLDB 12
  • NOTV 3
  • Target Price
  • SLDB $17.83
  • NOTV $5.92
  • AVG Volume (30 Days)
  • SLDB 5.4M
  • NOTV 701.6K
  • Earning Date
  • SLDB 03-12-2025
  • NOTV 02-05-2025
  • Dividend Yield
  • SLDB N/A
  • NOTV N/A
  • EPS Growth
  • SLDB N/A
  • NOTV N/A
  • EPS
  • SLDB N/A
  • NOTV N/A
  • Revenue
  • SLDB N/A
  • NOTV $475,114,000.00
  • Revenue This Year
  • SLDB N/A
  • NOTV $6.37
  • Revenue Next Year
  • SLDB N/A
  • NOTV $5.74
  • P/E Ratio
  • SLDB N/A
  • NOTV N/A
  • Revenue Growth
  • SLDB N/A
  • NOTV N/A
  • 52 Week Low
  • SLDB $2.88
  • NOTV $1.23
  • 52 Week High
  • SLDB $15.05
  • NOTV $11.42
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 69.94
  • NOTV 49.10
  • Support Level
  • SLDB $3.15
  • NOTV $3.58
  • Resistance Level
  • SLDB $7.20
  • NOTV $4.51
  • Average True Range (ATR)
  • SLDB 0.63
  • NOTV 0.42
  • MACD
  • SLDB 0.37
  • NOTV 0.01
  • Stochastic Oscillator
  • SLDB 67.13
  • NOTV 43.08

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: